[PDF] Top 20 1. -Prevención de riesgos laborales. Cuaderno FPO
Has 10000 "1. -Prevención de riesgos laborales. Cuaderno FPO" found on our website. Below are the top 20 most common "1. -Prevención de riesgos laborales. Cuaderno FPO".
Management of severe pulmonary arterial hypertension
... with severe, WHO FC IV disease is dismal, with rapid progress to end-stage disease and death in the absence of ...Therefore, severe PAH clearly requires rapid and aggressive treatment in order to achieve ... See full document
5
Optimal management of severe pulmonary arterial hypertension
... the pulmonary vascular changes characteristic of the disease: 1) the prostacyclin pathway, which plays a role in inducing pulmonary vasodila- tion and the inhibition of smooth muscle cell growth, is ... See full document
7
Severe pulmonary arterial hypertension: treatment options and the bridge to transplantation
... the management of PAH patients in a real-world setting, the PAH-Quality Enhancement Research Initiative, analysed data provided by physicians on the diagnosis, management and outcomes of patients with PAH ... See full document
21
Pregnancy in pulmonary arterial hypertension
... It is important that advice on effective contraceptive methods is given early following a PAH diagnosis and that there is appropriate collaboration and follow-up with a community gynaecologist. A summary of contraceptive ... See full document
163
The limits of oral therapy in pulmonary arterial hypertension management
... sildenafil, tadalafil, et al, because of its stability and convenient administration route, occupies an important position in the PAH management. However, when compar- ing with other routes of administration, oral ... See full document
71
Safety and tolerability of bosentan in the management of pulmonary arterial hypertension
... On the basis of a series of randomized controlled clinical trials, bosentan, ambris- entan, and sitaxsentan are the ERAs licensed in the United States and/or Europe as monotherapy for patients with Group 1 World Health ... See full document
5
Trends in pulmonary arterial hypertension
... It is now well known that mutations within the type-II bone morphogenic protein receptor gene (BMPRII) pre-dispose to the development of PAH [49]. Moreover, patients carrying the mutation develop the disease at an ... See full document
6
Patient engagement and self-management in pulmonary arterial hypertension
... delivering pulmonary hypertension care are trained in health coaching, since this can help patients gain a better understanding of their goals, how to achieve them and how to engage in the management ... See full document
134
Integrated care and optimal management of pulmonary arterial hypertension
... these symptoms are non-specific, PAH is often overlooked or under-recognized until its later, more advanced stages (such as the onset of right heart failure). This pattern of presentation may also be responsible for ... See full document
8
Update on pulmonary arterial hypertension in children: management strategies and clinical utility of sildenafil
... The PAH subdivisions represent the complex etiology of the condition. Moreover, recent changes in classification have distinguished a hereditary form (HPAH) from IPAH, where HPAH describes known inheritance or ... See full document
6
Early Results of Mitral Valve Replacement in Severe Pulmonary Artery Hypertension—An Institutional Prospective Study
... All preoperative assessments were carried out by 2- dimensional transthoracic echocardiography. Cardiac ca- theterization was not undertaken in any of these patients as per institutional protocol. Patients more than 40 ... See full document
249
Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
... more severe clinical and haemodynamic phenotype ...induce pulmonary vascular dysfunction at the level of endothelial cells and smooth muscle cells ... See full document
36
Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice
... of pulmonary arterial hypertension (PAH), a severe vascular disease characterized by chronically elevated pulmonary artery pressure and accompanied by remodeling of the small ... See full document
12
The spectrum of pulmonary arterial hypertension in adults with congenital heart disease: management from a physician and nurse specialist perspective
... monary hypertension CNS undergoes extensive training on all aspects of the disease and is able to manage both stable and deteriorating ...a management plan that will optimise outcomes and improve quality of ... See full document
6
The improvement of pulmonary artery pressure after bosentan therapy in patients with β-thalassemia and Doppler-defined pulmonary arterial hypertension
... Materials and methods: This study aimed at evaluating the effect of bosentan therapy on patients with thalassemia suspected of PAH. Based on pulsed Doppler echocardiography, all the cases were suspected of severe ... See full document
31
Platelet derived growth factor receptor β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno occlusive disease: a case control study
... resting pulmonary arterial pressure (mPpa) ≥25 mmHg and a pulmonary capillary wedge pressure ≤15 mmHg, were ...and/or severe fibrosis on HRCT scan were ...of pulmonary vascular disease ... See full document
11
Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment
... with severe PAH, targeting more than one of the three known pathological pathways of PAH is ...malignant hypertension, or in diseases where mortality rates are high, an upfront pre-emptive approach is ... See full document
41
Prostanoid therapies in the management of pulmonary arterial hypertension
... vasodilation. Pulmonary arterial hypertension (PAH) is characterized by elevated mean pulmonary artery pressure due to a high pulmonary vascular resistance ...the management of ... See full document
5
Early detection and management of pulmonary arterial hypertension
... delay progression of disease through early treatment [12]. Screening programmes play an important part in the detection of PAH in certain at-risk populations and may enable patients to be identified at an earlier stage ... See full document
11
Eisenmenger syndrome: current perspectives
... most severe form of pulmonary arterial hyperten- sion (PAH) related to congenital heart disease ...of pulmonary vascular disease (PVD) if the defect is not repaired in a timely ...Once ... See full document
26
Related subjects